Watch this webinar on-demand.

The FDA recently held their third public meeting with stakeholders to discuss the operation of the US pharma supply chain in 2023 and beyond under the Drug Supply Chain Security Act (DSCSA). The topics covered by the FDA for that meeting include:

• Further refinement of Enhanced Drug Distribution Security (EDDS) needs
• Building capacity for a unit-level system
• Verification of the DSCSA Product Identifier
• Identification and prioritization of “Guardrails” requested of the FDA by industry

In this webinar, Systech’s Regulatory Strategist, Dirk Rodgers, provided a recap and analysis of the meeting.  Even if you attend the FDA meeting yourself you will want to hear his perspectives on the implications to your future DSCSA compliance requirements. 

In addition, he reviewed the latest updates to the pharma serialization and traceability regulations around the globe.  Watch this informative and important webinar now.